Advanced Search
Contact | Corporate | Help

Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation

Sponsors:
  • Cedars-Sinai Medical Center
  • Genentech
  • Biogen Idec
Phases:
  • Phase I
  • Phase II
IndicationsAcronym:
  • Kidney Transplant
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: IVIG and Rituximab
Enrollment:
20

Additional information about NCT00642655.


SourceSolution © 2008-2012